- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.08. | Chugai spikes after Eli Lilly trial win for obesity pill | 19 | Seeking Alpha | ||
| 08.08. | Chugai stock drops the most since 1977 on disappointing obesity drug data | 26 | Japan Times | ||
| 24.07. | Chugai Pharmaceutical reports Q2 results | 9 | Seeking Alpha | ||
| 08.07. | Chugai and Gero link on antibody drugs for age-related conditions | 5 | Pharmaceutical Technology | ||
| CHUGAI PHARMACEUTICAL CO LTD ADR Aktie jetzt für 0€ handeln | |||||
| 19.06. | NEC Corporation: NEC and Chugai Pharmaceutical use AI to potentially enhance cancer treatment | 601 | JCN Newswire | - Identified the potential to reduce the time required to research and predict drug combinations by approximately 50% -TOKYO, June 18, 2025 - (JCN Newswire) - NEC Corporation (NEC; TSE: 6701), in collaboration... ► Artikel lesen | |
| 19.05. | Rani Therapeutics erforscht orale Verabreichung von Chugai-Medikamenten | 10 | Investing.com Deutsch | ||
| 19.05. | Rani Therapeutics explores oral delivery of Chugai's drugs | 4 | Investing.com | ||
| 19.05. | Rani Therapeutics Announces Research Agreement with Chugai | 460 | GlobeNewswire (Europe) | - Research agreement is evaluating feasibility of applying Rani's oral delivery technology to Chugai's antibodies against undisclosed targets - SAN JOSE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Rani... ► Artikel lesen | |
| 18.04. | Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai | 17 | Japan Times |
9 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TRULIEVE CANNABIS | 6,545 | +0,77 % | Trulieve Cannabis Corp: Trulieve to open dispensary in Arizona | ||
| WEST PHARMACEUTICAL SERVICES | 213,30 | -0,33 % | Dividendenbekanntmachungen (30.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACOMO NV NL0000313286 - 0,45 EUR BANK OF MONTREAL CA0636711016 1,63 CAD 1,0252 EUR CONAGRA BRANDS INC US2058871029 0,35 USD 0... ► Artikel lesen | |
| SHIONOGI | 15,200 | -1,30 % | Aktienmarkt: Shionogi-Aktie kann sich nicht behaupten (14,00 €) | Im Wertpapierhandel notiert die Shionogi-Aktie zur Stunde etwas leichter. Der jüngste Kurs betrug 14,00 Euro. Ein Minus in Höhe von 0,6 Euro müssen derzeit die Aktionäre von Shionogi hinnehmen. Aktuell... ► Artikel lesen | |
| KALA BIO | 12,290 | -1,29 % | KALA BIO, Inc.: KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director | ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative... ► Artikel lesen | |
| CHARLOTTES WEB | 0,082 | 0,00 % | Charlotte's Web Holdings Inc: Charlotte's Web to form scientific advisory board | ||
| BEXIMCO PHARMACEUTICALS | 0,500 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 03.07.2025 | The following instruments on XETRA do have their last trading day on 03.07.2025Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 03.07.2025ISIN NameAU3CB0222354 FMO-N.FIN.-M.O. 2025... ► Artikel lesen | |
| LUYE PHARMA | 0,412 | +3,52 % | LUYE PHARMA (02186): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2025 | ||
| PERCHERON THERAPEUTICS | 0,006 | +20,00 % | XFRA AWY0: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| MIRUM PHARMACEUTICALS | 64,50 | -0,77 % | Stifel resumes Mirum Pharmaceuticals stock coverage with Buy rating | ||
| AYURCANN | 0,012 | 0,00 % | Ayurcann Holdings Corp: Ayurcann omits Q3 net P&L in NR, talks revenue | ||
| AVANT BRANDS | 0,490 | -1,21 % | Avant Brands Inc.: Avant Brands Announces Results for Q2 2025 | KELOWNA, BC / ACCESS Newswire / July 15, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products,... ► Artikel lesen | |
| KALBE FARMA | 0,056 | 0,00 % | KLBF schedules IDR 250 billion buyback starting 4 September: KLBF to repurchase shares (buyback) worth IDR 250 ... | ||
| EVEREST MEDICINES | 6,550 | +1,55 % | Everest Medicines Limited: Everest Medicines Announces 2025 Interim Results: 'Dual-Engine' Strategy Driving Strong Synergies Between Commercialization and R&D | HONG KONG, Sept 1, 2025 - (ACN Newswire) - On August 29, Everest Medicines (1952.HK) announced its interim results for the six months ended June 30, 2025. The Company's total revenue for the first half... ► Artikel lesen | |
| KOBAYASHI PHARMACEUTICAL | 30,200 | -0,66 % | Dividendenbekanntmachungen (27.06.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGC INC JP3112000009 105 JPY 0,6216 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1795 EUR ALICO INC US0162301040 0... ► Artikel lesen | |
| SILO WELLNESS | 0,008 | -100,00 % | Silo Wellness Inc.: Silo Wellness Appoints Defense Finance Veteran Richard Craven as CEO to Guide Strategic Transition to Born Defense | Eugene, Oregon and Toronto, Ontario--(Newsfile Corp. - August 8, 2025) - Silo Wellness Inc. (CSE: SILO) ("Silo," or the "Company") is pleased to announce the appointment of Richard Craven as Chief... ► Artikel lesen |
CHUGAI PHARMACEUTICAL CO LTD ADR gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von +0,300 (+1,69 %) liegt der Kurs bei 18,100 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHUGAI PHARMACEUTICAL CO LTD ADR finden Sie auf Wallstreet Online.